MMC plus -interferon-line bladder control Bladder Cancer Recurrence.doc

 PAGE \* MERGEFORMAT 10 MMC plus -interferon-line bladder control Bladder Cancer Recurrence Study: Left Guozai Chen Jianqiang Wang Huiquan Yang Yuejun [Abstract] Objective: To investigate the MMC plus @ - IFN in bladder cancer after intravesical chemotherapy for preventing recurrence. Methods: 36 patients with bladder cancer were treated with partial cystectomy or transurethral resection of bladder tumor following the introduction of MMC 20 ~ 40mg + @ - interferon 3 million U + saline 40mL prevention of bladder tumor recurrence 18. Results: The 5-year follow-up, recurrence rate was 11% after reperfusion. Conclusion: The bladder cancer Wire mitomycin + @ - interferon chemotherapy to prevent recurrence of bladder, more effective, side effects. [Keywords:] bladder cancer, mitomycin C, interferon, relapse Abstract Objective: To study the effect of the MMC and alpha-interferon irrigation of bladder cancer recurrence after operation. Methods: Thirty six patients with bladder cancer were treated by the partial cystectomy or TUR-BT and The MMC 20 ~ 40mg + alpha-interferon 3mil.U + NS 40mL irrigation of bladder after operation to prevent cancer recurrence total 18 times. Results: The patients were followed up for 6 ~ 60 months, there were 4 cases getting recurrence, the recurrence rate was11.1%. Conclusion: The therapy is effective and the side effect is little. Keywords: Bladder cancer; MMC; Interferon; Recurrence In tumors of the urinary system, whether the incidence or mortality of bladder cancer in both the first in recent years, the incidence of growth trend. Higher recurrence rate of bladder cancer, the clinical use of intravesical drug treatment and prevention of bladder tumor recurrence many ways. in our hospital from January 2000 to January 2003 using mitomycin (MMC plus @ - interferon chemotherapy bladder to prevent bladder cancer recurrence, a total of 36 cases. The follow-up to obtain satisfactory results , reported as follows. 1 Mater